The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nanomaterials for Ocular Drug Delivery
Abstract
Efficient drug delivery to the eye remains a challenging task for pharmaceutical scientists. Due to the various anatomical barriers and the clearance mechanisms prevailing in the eye, conventional drug delivery systems, such as eye drop solutions, suffer from low bioavailability. More invasive methods, such as intravitreal injections and implants, cause adverse effects in the eye. Recently, an increasing number of scientists have turned to nanomaterial‐based drug delivery systems to address the challenges faced by conventional methods. This paper highlights recent applications of various nanomaterials, such as polymeric micelles, hydrogels, liposomes, niosomes, dendrimers, and cyclodextrins as ocular drug delivery systems to enhance the bioavailability of ocular therapeutic agents.magnified image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Hydrogels: From controlled release to pH-responsive drug delivery
Gupta, P., Vermani, K., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02255-9 · Cited by 1,825
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Polyhydroxyethylaspartamide-based micelles for ocular drug delivery
Civiale, C., Licciardi, M., Cavallaro, G., Giammona, G., & Mazzone, M. G. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.028 · Cited by 120
Di Tommaso, C., Torriglia, A., Furrer, P., Behar-Cohen, F., Gurny, R., & Möller, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.004 · Cited by 84
Cited by
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
“Recently, polymericmicelles have shown growing evidences as a potential nanocarrier to overcome such limitations and provide therapeutic drug concentrations in the ocular tissues of the anterior and posterior segments following topical administration [46,47].”
BackgroundBiodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 421
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Non-viral strategies for ocular gene delivery
Oliveira, A. V., Rosa da Costa, A. M., & Silva, G. A. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.04.068 · Cited by 80
“[9, 17, 22] Also, due to its size and charge, DNA is unable to cross the cornea and transfection is generally limited to the superficial epithelial layer.”
BackgroundInfluentialLi, Q., Lai, K. L., Chan, P. S., Leung, S. C., Li, H. Y., Fang, Y., To, K. K. W., Choi, C. H. J., Gao, Q. Y., & Lee, T. W. Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.053 · Cited by 67
Nguyen, D. C. T., Dowling, J., Ryan, R., McLoughlin, P., & Fitzhenry, L. (2021) · Contact Lens and Anterior Eye · doi:10.1016/j.clae.2021.101487 · Cited by 61
Li, Z., Liu, M., Ke, L., Wang, L.-J., Wu, C., Li, C., Li, Z., & Wu, Y.-L. (2021) · Nanoscale Advances · doi:10.1039/d1na00596k · Cited by 59
Nanoparticle-Mediated Expression of a Wnt Pathway Inhibitor Ameliorates Ocular Neovascularization
Wang, Z., Cheng, R., Lee, K., Tyagi, P., Ding, L., Kompella, U. B., Chen, J., Xu, X., & Ma, J.-X. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304627 · Cited by 38
Metadata
- Authors
- Liu, S., Jones, L., & Gu, F. X.
- Venue
- Macromolecular Bioscience
- Publisher
- Wiley
- Published
- 2012-04-17
- Volume
- 12
- Issue
- 5
- Pages
- 608-620
- ISSN
- 1616-5187 (ISSN-L)
- 1616-5195
- OpenAlex
- W2017700229
- Cited by
- 185
- References
- 5
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.